Finance

Beta
Lists
ENTA:NASDAQ
Enanta Pharmaceuticals Inc
$15.19
+4.18%
(+0.61) 1D
Jul 1, 10:05:17 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ENTA...
Open
$14.63
High
$15.19
Low
$14.63
Mkt. cap
432.25M
Avg. vol.
240.76K
Volume
16.67K
52-wk high
$17.15
52-wk low
$6.44
EPS
-$2.59
Beta
0.97
Shares outstanding
29.08M
No. of employees
120
Open
$14.63
High
$15.19
Low
$14.63
Mkt. cap
432.25M
Avg. vol.
240.76K
Volume
16.67K
52-wk high
$17.15
52-wk low
$6.44
EPS
-$2.59
Beta
0.97
Shares outstanding
29.08M
No. of employees
120
News stories
From sources across the web
About Enanta Pharmaceuticals Inc
CEO-
Employees120
Founded1995
HeadquartersWatertown, Massachusetts, United States
SectorBiotechnology
Websiteenanta.com
Analyst ratings
Based on 1 analyst giving stock ratings to ENTA in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for ENTA in the last 3 months
Highest
Current $15.19
$20.00 (+31.67%)
Average
$20.00 (+31.67%)
Lowest
$20.00 (+31.67%)
Analyst
Recommendation
Action
Price target
Projected
Date
Brandon Folkes
H.C. Wainwright
Buy
Reiterated
$20.00
+31.7%
06/23/2026
Unknown Analyst
Rodman & Renshaw
Buy
Initiated
$20.00
+31.7%
03/26/2026
Anupam Rama
J.P. Morgan
Buy
Maintained
$19.00
+25.1%
03/03/2026
Last report
May 11, 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
-$0.45 / -$0.57
+20.82%beat
Revenue / Est. (USD)
17.16M / 16.58M
+3.51%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
18.31M
15.12M
18.62M
17.16M
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
27.21M
23.81M
20.86M
19.44M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
10.00M
9.70M
9.01M
9.57M
Operating expense
37.21M
33.51M
29.87M
29.01M
Total operating expenses
37.21M
33.51M
29.87M
29.01M
Operating income
-18.89M
-18.39M
-11.25M
-11.85M
Other non operating income
-
39.00K
-
-
EBT including unusual items
-18.23M
-18.67M
-11.91M
-13.08M
EBT excluding unusual items
-18.23M
-19.63M
-11.89M
-13.08M
Income tax expense
29.00K
32.00K
24.00K
7.00K
Effective tax rate
-0.16%
-0.17%
-0.20%
-0.05%
Other operating expenses
-
-
-
-
Net income
-18.26M
-18.70M
-11.94M
-13.09M
Net profit margin
-99.68%
-123.64%
-64.13%
-76.29%
Earnings per share
-0.85
-0.87
-0.42
-0.45
Interest and investment income
2.28M
1.11M
2.44M
2.08M
Interest expense
-1.62M
-2.39M
-3.08M
-3.32M
Net interest expenses
667.00K
-1.28M
-641.00K
-1.23M
Depreciation and amortization charges
-
-
-
-
EBITDA
-17.68M
-17.10M
-10.02M
-10.64M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer